Status:
WITHDRAWN
Treatment of Cervical Pain in Chronic Migraine
Lead Sponsor:
University Hospitals Cleveland Medical Center
Conditions:
Chronic Migraine
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Chronic migraine (CM) is defined as a headache that occurs more than 15 days per month, which has the features of migraine headache on at least 8 days per month.1 The cause of CM is not well understoo...
Detailed Description
Data will be analyzed by reviewing the amount of headache days during the treatment period Patients will be distributed randomly into either the treatment arm or control arm. Subjects will be randomi...
Eligibility Criteria
Inclusion
- Patients aged 18-80 years of age who fit the ICHD-3 criteria for Chronic Migraine. These patients must be currently on an abortive agent (such as a triptans, NSAIDs) and require at least 8 doses a month.
Exclusion
- Patients will be excluded if there are any signs of secondary headaches. If they have received BOTOX therapy in the past 4 months or are currently receiving BOTOX therapy. If the patients have contraindications to counterstrain OMT (clinical signs of Fractures, ligament instability, severe vertebral artery disease) or are a poor candidate for OMT (unable to follow commands, unable to fully relax).
Key Trial Info
Start Date :
April 29 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 29 2018
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03453203
Start Date
April 29 2018
End Date
December 29 2018
Last Update
May 5 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.